EUVIMEDScopri EUVIMED
CrossrefScheda informativa

Ethylene Glycol Poisoning in Two Griffon Vultures (Gyps fulvus) in Italy

Caterina Raso, Claudia Eleni, Lorena Di Benedetto, Claudia Focardi, Anna Ciogli, Gianluca Lelli, Mario Posillico, Nicolò Borgianni, Gianpiero Di Clemente, Goffredo Grifoni

Journal of Wildlife Diseases · 2026-11-04 · 62 (4) · 1019-1025

DOI: 10.7589/jwd-d-25-00188 ↗
AbstractDati bibliografici

Abstract

Poisoning is a major cause of anthropogenic death and population decline in vultures, posing a serious conservation problem for several species. This report describes mortality consequent to ethylene glycol (EG) poisoning in two Griffon Vultures Gyps fulvus in Italy. One was observed alive showing abnormal hypoactive behavior 3 d before corpse retrieval. At necropsy, the main pathologic findings of severe tubulonephrosis with accumulation of oxalate crystals and hepatocellular necrosis in both animals were strongly suggestive of EG poisoning, confirmed by chemical analysis of the liver and gastric contents. Estimated postmortem intervals dated both deaths to the same 72 h timeframe, suggesting a common source of exposure and indicating that the bird seen alive died soon afterwards. An alcoholic compound, EG is widely used as an antifreeze or industrial solvent and frequently detected in poisoning casualties. It has a sweet taste, and animals may consume it unintentionally, in poisoned baits, or by scavenging poisoned carcasses. Although the source of the toxin for these vultures remains unknown, this report underlines the importance of vultures' post-mortem surveillance for the early detection of environmental contaminants and conservation threats. According to the available literature, EG poisoning has not previously been reported in any vultures in Europe nor in Griffon Vultures worldwide.

Conoscenze adatte al tuo lavoro.

Dall’inizio gratuito alla ricerca bibliografica personale, fino alla Research Suite completa.

Visualizza tariffe →

Sono inclusi tutti i testi integrali degli editori?

No. Citazioni, abstract e testi integrali sono contenuti diversi. La disponibilità dipende dalla fonte, dall’accesso aperto e dalle licenze esistenti. Un piano EUVIMED non sostituisce diritti aggiuntivi degli editori.

Visualizza tariffe →